Related references
Note: Only part of the references are listed.Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
J. Gao et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Overcoming acquired resistance of gefitinib in lung cancer cells without T790M by AZD9291 or Twist1 knockdown in vitro and in vivo
Zhongwei Liu et al.
ARCHIVES OF TOXICOLOGY (2019)
Synergistic effect of PLGA nanoparticles and submicron triglyceride droplets in enhancing the intestinal solubilisation of a lipophilic weak base
Paul Joyce et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer
Shang-Gin Wu et al.
MOLECULAR CANCER (2018)
PLGA Nanoparticles and Polysorbate-80-coated PLGA Nanoparficles Increase the in vitro Antioxidant Activity of Melatonin
Leiziani Gnatkowski Martins et al.
CURRENT DRUG DELIVERY (2018)
A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer
Weidong Han et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Purification of Drug Loaded PLGA Nanoparticles Prepared by Emulsification Solvent Evaporation Using Stirred Cell Ultrafiltration Technique
Suresh K. Paswan et al.
PHARMACEUTICAL RESEARCH (2017)
Antitumor activity of high-dose pulsatile gefitinib in non-small-cell lung cancer with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors
Yitao Wan et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Fatemeh Sadat Tabatabaei Mirakabad et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Quercetin-Loaded Microcapsules Ameliorate Experimental Colitis in Mice by Anti-inflammatory and Antioxidant Mechanisms
Carla F. S. Guazelli et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Quercetin liposomes protect against radiation-induced pulmonary injury in a murine model
Hao Liu et al.
ONCOLOGY LETTERS (2013)
Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy?
N. R. Budha et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Quercetin enhances the effects of 5-fluorouracil-mediated growth inhibition and apoptosis of esophageal cancer cells by inhibiting NF-κB
Lu Chuang-Xin et al.
ONCOLOGY LETTERS (2012)
Oral bioavailability of quercetin from different quercetin glycosides in dogs
Marianne Reinboth et al.
BRITISH JOURNAL OF NUTRITION (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Share Paper
